Skip to main navigation Skip to search Skip to main content

MGT-AQP1-201 - A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of AAV2-hAQP1 Gene Therapy in Participants with Radiation Induced Parotid Gland Hypofunction and Xerostomia

Project: Research

Project Details

StatusActive
Effective start/end date11/30/2312/31/26

Funding

  • MeiraGTx Limited Liability Corporation: $228,592.05